Mylan has been in the news for hiking prices on its EpiPen. The stock is flat since we recommended it in March, but we now ...
to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited (“Mylan”) for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane,” the ...
Keeping that in mind, here is one healthcare stock poised to generate sustainable market-beating returns and two we’re swiping left on. Formed in 2020 through the merger of Mylan and Upjohn ...